Jefferies puts Bavarian Nordic on hold

Bavarian Nordic A/S was rated at hold by Jefferies & Co., Inc. analyst Robin Campbell on news of the delayed U.S. Government smallpox vaccine contract. The company is in the dark in regards to timing and, according to the analyst, forecasts are increasingly threatened. Shares of the Kvistgard, Denmark-based pharmaceutical company were up kr9, or 2.39%, at kr385, on volume of 34,005 shares versus the three-month running average of 12,876 shares. (Copenhagen: BAVA)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.